Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019

Xiaoning Wu(Hebei Medical University), Xu‐Feng Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Jingjing Hou(Zhongshan Hospital of Xiamen University), Junxi Xiang(First Affiliated Hospital of Xi'an Jiaotong University), Feng Xue(Chinese Center For Disease Control and Prevention), Nan Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Wei Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Yi Lv(Xi'an Jiaotong University)
BMC Public Health
February 3, 2024
10.1186/s12889-024-17948-6
Cited by 123

Related Papers

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis
|ACS Nano|2023|142
CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1
|Current Biology|1996|138
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
|Clinical Gastroenterology and Hepatology|2020|115
Hypertension prevalence and status of awareness, treatment and control in China.
|PubMed|1995|87